<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PSA Rising Prostate Cancer Blog &#187; Cancer Treatments</title>
	<atom:link href="http://www.psa-rising.com/blog/category/ca/ca-tx/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.psa-rising.com/blog</link>
	<description></description>
	<lastBuildDate>Tue, 16 Aug 2011 09:39:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Disparities in cancer care reflect hospital resources, U-M study finds</title>
		<link>http://www.psa-rising.com/blog/2009/08/disparities-in-cancer-care-reflect-hospital-resources-u-m-study-finds/</link>
		<comments>http://www.psa-rising.com/blog/2009/08/disparities-in-cancer-care-reflect-hospital-resources-u-m-study-finds/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 15:24:59 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Breast]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer Treatments]]></category>
		<category><![CDATA[Colorectal]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=1436</guid>
		<description><![CDATA[If you are a cancer patient, whatever your race &#8212; whether you are African American, Hispanic or white &#8212; in the USA you would be well advised to seek treatment at a hospital that treats mostly white patients. So finds a newly published study by researchers at University of Michigan Comprehensive Cancer Center. At hospitals [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/08/disparities-in-cancer-care-reflect-hospital-resources-u-m-study-finds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What your oncologists can learn about prostate cancer this fall</title>
		<link>http://www.psa-rising.com/blog/2009/08/what-your-oncologists-can-learn-about-prostate-cancer-this-fall/</link>
		<comments>http://www.psa-rising.com/blog/2009/08/what-your-oncologists-can-learn-about-prostate-cancer-this-fall/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 13:47:43 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer Treatments]]></category>
		<category><![CDATA[Prostate Cancer]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=1430</guid>
		<description><![CDATA[For a glimpse into what your oncologist can learn about prostate cancer this fall check out the agenda for this October 31, 2009 conference. Unfortunately, for prostate cancer this learning session reflects no rapid advancements in standard of care. But if your oncologist falls beneath this standard, find someone better: Sixth Annual Current Trends in [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/08/what-your-oncologists-can-learn-about-prostate-cancer-this-fall/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer</title>
		<link>http://www.psa-rising.com/blog/2009/08/denosumab-in-men-receiving-androgen-deprivation-therapy-for-prostate-cancer/</link>
		<comments>http://www.psa-rising.com/blog/2009/08/denosumab-in-men-receiving-androgen-deprivation-therapy-for-prostate-cancer/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 12:48:46 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Denosumab]]></category>
		<category><![CDATA[Hormonal-ADT]]></category>
		<category><![CDATA[Osteoporosis]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Side Effects]]></category>
		<category><![CDATA[trial results]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=1425</guid>
		<description><![CDATA[Androgen-deprivation therapy is well-established for treating prostate cancer but is associated with bone loss and an increased risk of fracture. Matthew R. Smith and an international team investigated the effects of denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor-{kappa}B ligand, on bone mineral density and fractures in men receiving androgen-deprivation therapy [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/08/denosumab-in-men-receiving-androgen-deprivation-therapy-for-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Proton Therapy On Pres. Obama&#8217;s Health-Care Hatchet List?</title>
		<link>http://www.psa-rising.com/blog/2009/07/is-proton-beam-therapy-on-obamas/</link>
		<comments>http://www.psa-rising.com/blog/2009/07/is-proton-beam-therapy-on-obamas/#comments</comments>
		<pubDate>Wed, 08 Jul 2009 14:34:47 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Beam Radiation]]></category>
		<category><![CDATA[PCa Treatments]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Proton]]></category>
		<category><![CDATA[Side Effects]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=1318</guid>
		<description><![CDATA[Proton beam therapy for prostate cancer, a treatment that attracts more than an average numbers of engineers, scientists and pilots, is coming under intense scrutiny from reporters who expect it to be questioned by the Obama adminstration&#8217;s health-care reform team. In an article in today&#8217;s New York Times, &#8220;In Health Reform, a Cancer Offers an [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/07/is-proton-beam-therapy-on-obamas/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investor Interviews Hy Levitsky M.D. on Provenge</title>
		<link>http://www.psa-rising.com/blog/2009/04/investorv-interview-with-hy-levitsky/</link>
		<comments>http://www.psa-rising.com/blog/2009/04/investorv-interview-with-hy-levitsky/#comments</comments>
		<pubDate>Thu, 23 Apr 2009 03:50:15 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Biotech companies]]></category>
		<category><![CDATA[Cancer Treatments]]></category>
		<category><![CDATA[Dendreon]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Provenge]]></category>
		<category><![CDATA[trial results]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Add new tag]]></category>
		<category><![CDATA[Dendreon IV board]]></category>
		<category><![CDATA[HY Levitsky M.D.]]></category>
		<category><![CDATA[rufustoehee]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=1177</guid>
		<description><![CDATA[A four part interview with  Hy Levitsky M.D., professor of oncology and tumor immunology at Johns Hopkins Medical School and co-inventor GVAX anti-cancer vaccine, is posted on Dendreon Investor Village website. Interview conducted by rufustoehee, a dentist and Dendreon investor, published 4/22/2009. By way of introduction, Dr Levitsky&#8217;s bio is posted alphabetically downpage among those [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/04/investorv-interview-with-hy-levitsky/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Provenge Significantly Extends Survival of Men With Advanced Prostate Cancer, Dendreon Says</title>
		<link>http://www.psa-rising.com/blog/2009/04/951/</link>
		<comments>http://www.psa-rising.com/blog/2009/04/951/#comments</comments>
		<pubDate>Tue, 14 Apr 2009 15:15:45 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer Treatments]]></category>
		<category><![CDATA[Dendreon]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Provenge]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=951</guid>
		<description><![CDATA[Dendreon&#8217;s prostate cancer vaccine significantly prolonged the overall survival among 500 men with advanced, metastic  prostate cancer  compared to a placebo, the company said Tuesday. Results were &#8220;robust&#8221; and &#8220;unambiguous,&#8221; a spokesman said during today&#8217;s (Tues April 14) company broadcast conference call with biotech investment analysts. &#8220;The successful outcome from the Phase 3 IMPACT study [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/04/951/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bisphosphonate Side Effects and a New Clinical Trial</title>
		<link>http://www.psa-rising.com/blog/2009/01/bisphosphonates/</link>
		<comments>http://www.psa-rising.com/blog/2009/01/bisphosphonates/#comments</comments>
		<pubDate>Thu, 01 Jan 2009 06:40:48 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Cancer Treatments]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Esophageal]]></category>
		<category><![CDATA[Osteoporosis]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Side Effects]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[rHuPH20]]></category>
		<category><![CDATA[Zometa]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=890</guid>
		<description><![CDATA[Recent stories on bisphosphonate side effects might be signaling the advent of a new, superior drug, but will Halozyme&#8217;s rHuPH20 enzyme solve the problem of jaw necrosis? Drug development companies operate within the overall consumer culture. We all want better drugs, better everything. Generic Fosamax (alendronate) now costs just $4 at Wal-Mart, Kroger and other [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/01/bisphosphonates/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Fosamax Linked to Esophageal Cancer</title>
		<link>http://www.psa-rising.com/blog/2008/12/fosamax-linked-to-esophageal-cancer/</link>
		<comments>http://www.psa-rising.com/blog/2008/12/fosamax-linked-to-esophageal-cancer/#comments</comments>
		<pubDate>Thu, 01 Jan 2009 00:41:27 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Esophageal]]></category>
		<category><![CDATA[Osteoporosis]]></category>
		<category><![CDATA[Side Effects]]></category>
		<category><![CDATA[Fosamax]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=879</guid>
		<description><![CDATA[Diane Wysowski of the FDA&#8217;s division of drug risk assessment says researchers should check into potential links between oral bisphosphonate drugs and cancer of the esophagus. Merck&#8217;s oral osteoporosis drug Fosamax may carry a risk for esophageal cancer, Wysowski writes in a letter to January 1, 2009 New England Journal of Medicine. Bisphosphonates are a [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2008/12/fosamax-linked-to-esophageal-cancer/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Music Therapy Helps Relieve Anxiety of Cancer</title>
		<link>http://www.psa-rising.com/blog/2008/12/music-therapy-helps-relieve-anxiety-of-cancer/</link>
		<comments>http://www.psa-rising.com/blog/2008/12/music-therapy-helps-relieve-anxiety-of-cancer/#comments</comments>
		<pubDate>Fri, 19 Dec 2008 07:37:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer Treatments]]></category>
		<category><![CDATA[Complementary + Alt Med]]></category>
		<category><![CDATA[Complementary integrative]]></category>
		<category><![CDATA[QOL]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=752</guid>
		<description><![CDATA[Music &#8220;has Charms to sooth a savage Breast,&#8221; wrote playwright William Congreve, &#8220;To soften Rocks, or bend a knotted Oak.&#8221; But can it soothe those mired in the grief, confusion and pain of cancer diagnosis and treatment? Music therapist Megan Gunnell at the University of Michigan Comprehensive Cancer Center thinks so. She uses music to [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2008/12/music-therapy-helps-relieve-anxiety-of-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://www.cancer.med.umich.edu/musictherapy.mp3" length="13614627" type="audio/mpeg" />
		</item>
		<item>
		<title>Clinical Sexologist and Therapist Joins Krongrad Institute</title>
		<link>http://www.psa-rising.com/blog/2008/11/clinical-sexologist-and-therapist-joins-krongrad-institute/</link>
		<comments>http://www.psa-rising.com/blog/2008/11/clinical-sexologist-and-therapist-joins-krongrad-institute/#comments</comments>
		<pubDate>Mon, 24 Nov 2008 05:56:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ED]]></category>
		<category><![CDATA[Erectile dysfunction]]></category>
		<category><![CDATA[intimacy]]></category>
		<category><![CDATA[PCa Treatments]]></category>
		<category><![CDATA[Penile rehab]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[QOL]]></category>
		<category><![CDATA[Side Effects]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=583</guid>
		<description><![CDATA[Rhonda Fine PhD ARNP Many factors can adversely affect sexual performance. Physical disability illness, obesity, medications, aging, stress, grief, emotional distress and relationship conflicts may all at times contribute to sexual dysfunction. Prostate cancer diagnosis and treatment may also contribute to sexual dysfunction. To help men and their partners cope with and manage sexual dysfunction, [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2008/11/clinical-sexologist-and-therapist-joins-krongrad-institute/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

